Moderna now anticipates ending 2025 with cash and cash equivalents worth $8.1 billion, up from its previous forecast of ...

Merck has other promising candidates in its late-stage pipeline, such as enlicitide decanoate/MK-0616, an oral PCSK9 ...

TBG is an actively managed fund comprised of 30-40 U.S. stocks with solid track records of increasing dividends. See why the ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

Ms Indranee was speaking on a motion expressing regret at Mr Singh’s conduct. Read more at straitstimes.com. Read more at ...

Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...

Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these fresh ...

With that as the backdrop, here's a rundown of three dividend stocks to buy with plans to only hold them for the next 10 ...

These five Dogs of the Dow may be the perfect play for 2026 for growth and income investors wary of volatility and a ...

Dow Jones Industrial Average, Chevron Corp, Coca-Cola Co, Merck & Company Inc. Read 's Market Analysis on Investing.com ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

Merck is in talks to buy cancer drug developer Revolution Medicines, the Financial Times reported on Thursday, citing people ...